PLIANT THERAPEUTICS, INC.

PLRXSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1746473

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$0.00	$9.7M	$7.6M	$7.6M	$57.1M
Research and Development Expense	$169.3M	$96.9M	$77.5M	$77.5M	$47.4M
Operating Expenses	$228.4M	$136.9M	$105.1M	$105.1M	$58.3M
Operating Income (Loss)	-$228.4M	-$127.2M	-$97.5M	-$97.5M	-$1.2M
Interest Expense	—	—	$0.00	$0.00	—
Other Nonoperating Income (Expense)	—	—	—	—	—
Income Tax Expense (Benefit)	$0.00	$0.00	$0.00	$0.00

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$396.9M	$512.2M	$350.6M	$221.2M	$295.5M
Assets, Current	$362.3M	$505.5M	$340.3M	$209.4M	$290.8M
Cash and Cash Equivalents, at Carrying Value	$71.2M	$63.2M	$33.7M	$51.7M	$50.9M
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	$2.0M	$2.0M	$9.3M
Liabilities	$92.9M	$38.6M	$37.3M	$22.2M	$12.5M
Liabilities, Current	$33.2M	$28.5M	$23.9M	$16.8M	$11.6M
Long-term Debt	$30.2M	$10.1M	$9.9M	$0.00

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$155.5M	-$94.6M	-$75.4M	-$75.4M	-$2.8M
Net Cash Provided by (Used in) Investing Activities	$140.3M	-$150.2M	$73.7M	$73.7M	-$17.9M
Net Cash Provided by (Used in) Financing Activities	$23.1M	$226.9M	$2.5M	$2.5M	$45.5M
Payments to Acquire Property, Plant, and Equipment	$3.8M	$1.8M	$2.0M	$2.0M	$964.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)